Literature DB >> 2272030

New cytostatics--more activity and less toxicity.

M R Berger1, H Richter, M H Seelig, H Eibl, D Schmähl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2272030     DOI： 10.1016/0305-7372(90)90039-i

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  10 in total

1.  Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica.

Authors:  K Seifert; M Duchêne; W H Wernsdorfer; H Kollaritsch; O Scheiner; G Wiedermann; T Hottkowitz; H Eibl
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  [Spectrographic studies on the radioresistance of Miltex and miltefosine].

Authors:  G Bollmann; H Paukisch; E Bothe; W Strate; G Gademann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

3.  Chronic oral administration of CI-994: a phase 1 study.

Authors:  S Prakash; B J Foster; M Meyer; A Wozniak; L K Heilbrun; L Flaherty; M Zalupski; L Radulovic; M Valdivieso; P M LoRusso
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

4.  Preclinical antitumor activity of CI-994.

Authors:  P M LoRusso; L Demchik; B Foster; J Knight; M C Bissery; L M Polin; W R Leopold; T H Corbett
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

5.  Preclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogs.

Authors:  M J Graziano; G D Pilcher; K M Walsh; O B Kasali; L Radulovic
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 6.  Signal transduction pathways: new targets in oncology.

Authors:  R K Sweeb; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-12-17

7.  Hexadecylphosphocholine differs from conventional cytostatic agents.

Authors:  M R Berger; B Betsch; M Gebelein; E Amtmann; P Heyl; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.

Authors:  P Kaufmann-Kolle; J Drevs; M R Berger; J Kötting; N Marschner; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Induction of Apoptosis in Rat Peripheral Blood Lymphocytes by the Anticancer Drug CI-994 (Acetyldinaline)(*).

Authors:  Michael J. Graziano; Teresa A. Spoon; Erin A. Cockrell; Paul E. Rowse; Andrea J. Gonzales
Journal:  J Biomed Biotechnol       Date:  2001

10.  CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies.

Authors:  Nathan O Fuller; Antonella Pirone; Berkley A Lynch; Michael C Hewitt; Maria S Quinton; Timothy D McKee; Magnus Ivarsson
Journal:  ACS Chem Neurosci       Date:  2018-12-13       Impact factor: 4.418
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.